Wikidata entity: Q420164
C₆₄₆₈H₁₀₀₆₆N₁₇₃₂O₂₀₀₅S₄₀ (P274)
Quantities
| P4250 | defined daily dose | 0.13 |
| P2067 | mass | 145453.8 |
| P3780 | active ingredient in | ... | Q29006120 (Lemtrada) | Lemtrada |
| P3780 | active ingredient in | ... | Q29006154 (Mabcampath) | Mabcampath |
| P373 | Commons category | String | Alemtuzumab | ??? |
| P1552 | has characteristic | ... | Q679692 (biopharmaceutical) | biopharmaceutical |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Alemtuzumab%20Fab%201CE1.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P2175 | medical condition treated | ... | Q8277 (multiple sclerosis) | multiple sclerosis |
| P2175 | medical condition treated | ... | Q1088156 (chronic lymphocytic leukemia) | chronic lymphocytic leukemia |
| P2175 | medical condition treated | ... | Q1891209 (mycosis fungoides) | mycosis fungoides |
| P2175 | medical condition treated | ... | Q17152512 (T-cell prolymphocytic leukemia) | T-cell prolymphocytic leukemia |
| P2175 | medical condition treated | ... | Q18555066 (relapsing-remitting multiple sclerosis) | relapsing-remitting multiple sclerosis |
| P3489 | pregnancy category | ... | Q3679233 (Australian pregnancy category B2) | Australian pregnancy category B2 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q422248 (monoclonal antibody) | monoclonal antibody |
| P2868 | subject has role | ... | Q50429626 (immunological antineoplastic agent) | immunological antineoplastic agent |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | alemtuzumab | ??? |
| P267 | ATC code | L04AA34 |
| P231 | CAS Registry Number | 216503-57-0 |
| P592 | ChEMBL ID | CHEMBL1201587 |
| P9272 | DeCS ID | 57065 |
| P715 | DrugBank ID | DB00087 |
| P1417 | Encyclopædia Britannica Online ID | topic/Alemtuzumab |
| P646 | Freebase ID | /m/088m9m |
| P595 | Guide to Pharmacology Ligand ID | 6770 |
| P2062 | HSDB ID | 8177 |
| P7830 | LiverTox ID | Alemtuzumab |
| P10245 | MedlinePlus drug identifier | a608053 |
| P10245 | MedlinePlus drug identifier | a619012 |
| P486 | MeSH descriptor ID | D000074323 |
| P672 | MeSH tree code | D12.776.124.486.485.114.224.060.313 |
| P672 | MeSH tree code | D12.776.124.790.651.114.224.060.375 |
| P672 | MeSH tree code | D12.776.377.715.548.114.224.200.375 |
| P6366 | Microsoft Academic ID (discontinued) | 2779015954 |
| P2115 | NDF-RT ID | N0000148705 |
| P691 | NL CR AUT ID | ph370231 |
| P10283 | OpenAlex ID | C2779015954 |
| P3345 | RxNorm CUI | 117055 |
| P652 | UNII | 3A189DH42V |
| P11143 | WikiProjectMed ID | Alemtuzumab |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 8005 |
Why not click here or view trends?
log id: 3451940